{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:25:24Z","timestamp":1720283124573},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.diabres.2016.10.020","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T09:16:12Z","timestamp":1478164572000},"page":"162-169","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluation of patients with type 2 diabetes mellitus receiving treatment during the pre-diabetes period: Is early treatment associated with improved outcomes?"],"prefix":"10.1016","volume":"122","author":[{"given":"Paresh","family":"Chaudhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Vallarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest H.","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raafat","family":"Seifeldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2016.10.020_b0005","series-title":"National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014","author":"Centers for Disease Control and Prevention","year":"2014"},{"key":"10.1016\/j.diabres.2016.10.020_h0010","series-title":"Diabetes and impaired glucose tolerance. IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2012"},{"key":"10.1016\/j.diabres.2016.10.020_h0015","unstructured":"International Diabetes Federation. Diabetes and impaired glucose tolerance. IDF Diabetes Atlas, 5th ed. Brussels, Belgium: International Diabetes Federation, 2012."},{"key":"10.1016\/j.diabres.2016.10.020_b0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2016.10.020_b0020","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/dc15-S004","article-title":"Strategies for improving care. Sec. 1. In Standards of Medical Care in Diabetes-2015","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2016.10.020_b0025","first-page":"27","article-title":"Management of blood glucose with noninsulin therapies in type 2 diabetes","volume":"92","author":"George","year":"2015","journal-title":"Am Fam Physician"},{"issue":"10","key":"10.1016\/j.diabres.2016.10.020_b0030","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s40265-015-0416-8","article-title":"Therapeutic use of metformin in prediabetes and diabetes prevention","volume":"75","author":"Hostalek","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.diabres.2016.10.020_b0035","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","author":"Diabetes Prevention Program Research Group","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2016.10.020_b0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/M14-1773","article-title":"Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study","volume":"162","author":"Moin","year":"2015","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.diabres.2016.10.020_b0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4239\/wjd.v6.i2.296","article-title":"Prediabetes diagnosis and treatment: a review","volume":"6","author":"Bansal","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/j.diabres.2016.10.020_b0050","unstructured":"SAS version 9.4. Cary, NC, USA: SAS Institute Inc.; 2013"},{"key":"10.1016\/j.diabres.2016.10.020_b0055","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1464-5491.2011.03303.x","article-title":"Oral anti-diabetic drugs for the prevention of type 2 diabetes","volume":"28","author":"Phung","year":"2011","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.diabres.2016.10.020_b0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.amepre.2013.04.017","article-title":"Lifetime direct medical costs of treating type 2 diabetes and diabetic complications","volume":"45","author":"Zhuo","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.diabres.2016.10.020_b0065","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2016.10.020_b0070","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.diabres.2016.10.020_b0075","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1377\/hlthaff.2010.0819","article-title":"Potential savings in Mexico from screening and prevention for early diabetes and hypertension","volume":"29","author":"Castro-R\u00edos","year":"2010","journal-title":"Health Aff"},{"key":"10.1016\/j.diabres.2016.10.020_b0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/PPA.S14477","article-title":"Multinational internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication","volume":"4","author":"DiBonaventura","year":"2010","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"10.1016\/j.diabres.2016.10.020_b0085","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2337\/dc09-1184","article-title":"Barriers to insulin initiation: the translating research into action for diabetes insulin starts project","volume":"33","author":"Karter","year":"2010","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2016.10.020_b0090","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1185\/030079907X242638","article-title":"Barriers to the initiation of, and persistence with, insulin therapy","volume":"23","author":"Oliveria","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.diabres.2016.10.020_b0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/dc12-0733","article-title":"Pretreatment, psychological, and behavioral predictors of weight outcomes among lifestyle intervention participants in the Diabetes Prevention Program (DPP)","volume":"36","author":"Delahanty","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716315030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716315030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T01:20:54Z","timestamp":1536283254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822716315030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":20,"alternative-id":["S0168822716315030"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2016.10.020","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of patients with type 2 diabetes mellitus receiving treatment during the pre-diabetes period: Is early treatment associated with improved outcomes?","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2016.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}